Anyeep
Chemical analysis and medical detection mass spectrometers
About Anyeep
Based in Suzhou, China, Anyeep is a high-tech enterprise established in 2016 by Dr. Zhang Xiaohua, a recipient of the National Science and Technology Progress Second Class Award. The company operates within the diagnostic equipment and life sciences sectors, focusing on the development and manufacturing of spectroscopy instruments.
Anyeep's core business revolves around the research, production, and sale of chemical analysis and medical testing instruments. Its product portfolio includes a range of mass spectrometers, such as laboratory, portable, and high-resolution models. The company has developed various gas chromatography-mass spectrometry (GC-MS) instruments, including single and triple quadrupole systems, designed to offer solutions for both general-purpose and complex, trace-level detection. These products serve applications in fields like environmental assessment, food safety, and industrial manufacturing.
The company's business model is centered on direct sales of its instruments. Anyeep is privately held and backed by venture capital. It completed a Series A funding round on November 25, 2022, raising $13.9M from investors including Green River Investment, Honest Capital, and CreditEase.
Dr. Zhang Xiaohua founded the company with the stated mission of advancing domestic manufacturing of analytical instruments. Anyeep markets its products as providing high sensitivity, precision, and robustness to meet various market demands. The firm's target clients include laboratories and organizations involved in chemical analysis and medical testing.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Suzhou Shi, China
- Open positions
- None listed
- Dealroom signal
- 21.3/100
- Industry
- Health, Engineering and Manufacturing Equipment
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, biotech medtech and e-health, DT and LS, science-based
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Dec 2025 | $14M | $55M | Yuansheng BioVenture · Green Pine Capital · BioTrack Capital · Haineng Future Technology Group | ↗ |
| SERIES A✓Equity / VC | Nov 2022 | $14M | $55M | Yuansheng Venture Capital · Junshan Private Equity · Dunxing Capital · Green River Investment | ↗ |
Growth signals
Latest recorded traffic for Anyeep is 4.4K monthly website visits, up 621.3% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A9 investors entered at this stage
- YCYuansheng Venture Capital
- JEJunshan Private Equity
- DCDunxing Capital
- GIGreen River Investment
- FCFengrui Capital
Green Pine Capital
BioTrack Capital
Yuansheng BioVenture- HGHaineng Future Technology Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Anyeep on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Anyeep’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







